Navigation Links
It's 99 percent certain: Research cannot rely on adult stem cells alone

Stem Cell
MADISONIn the first debate of Wisconsin's U.S. Senate campaign, Republican Tim Michels dismissed scientific research using human embryonic stem cells as little more than an inconsequential sideshow. Michels said he supports the 99 percent of stem cell research that uses adult stem cells ......

Full article >>> rch revolves around producing cells for bone marrow, insulin-producing pancreatic islet cells, neural tissue, heart tissue and muscle.

Embryonic stem cell technology, combined with the recent mapping of the human genome system, also has the potential to speed up the often-laborious and imprecise process of drug discovery. It also offers a fascinating glimpse into the earliest stages of hu......

Full article >>> y to proliferate into quantities that can be effectively used in research or therapy. They can be dangerous to extract from some organs, such as the brain. As humans agewhen such cells are needed the mostthey become ever rarer. Adult stem cells may also exhibit genetic defects from exposure to toxins and sunlight. Perhaps most important, the targeted disease for stem cell therapy may already be lu......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 10/04/04


Related biology technology :

1. National angel investment grew 11 percent in `06
2. Musicnotes reports 45 percent growth in 2006
3. Fiserv posts 30 percent quarterly loss
4. RedPrairie exec calls for 50 percent tax cut
5. Renaissance earnings down 46 percent
6. GE Healthcare third-quarter profits up 17 percent
7. Criticare reports 20.3 percent increase in sales
8. The 3 percent solution: Unpopular drug companies still push discovery
9. Rockwell Automation ups quarterly dividend by 36 percent
10. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
11. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... Winston-Salem, NC (PRWEB) , ... February 23, 2017 , ... ... pleased to announce a new partnership with Compass Research . GGI's mission is ... gifting a vaccine to a child in need in honor of each clinical trial ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, ... on emerging technology, announces the availability of a new report, ... Continue Reading ... ... industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
Breaking Biology News(10 mins):